You have 9 free searches left this month | for more free features.

Chelation

Showing 1 - 25 of 252

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Gadolinium Deposition Disease Trial (Calcium DTPA and Zinc DTPA)

Not yet recruiting
  • Gadolinium Deposition Disease
  • Calcium DTPA and Zinc DTPA
  • (no location specified)
Oct 26, 2022

Stroke Trial in Bordeaux, Lille, Montpellier (Magnetic Resonance Imaging (MRI), Deferiprone treatment)

Recruiting
  • Stroke
  • Magnetic Resonance Imaging (MRI)
  • Deferiprone treatment
  • Bordeaux, France
  • +2 more
Jun 9, 2022

Sickle Cell Disease Trial in Amsterdam (Deferasirox 360 MG)

Recruiting
  • Sickle Cell Disease
  • Deferasirox 360 MG
  • Amsterdam, Meibergdreef 9, Netherlands
    Amsterdan UMC location AMC
May 23, 2022

Critical Limb Ischemia, Diabetes Trial in Miami Beach (Edetate Disodium, Placebo)

Recruiting
  • Critical Limb Ischemia
  • Diabetes
  • Edetate Disodium
  • Placebo
  • Miami Beach, Florida
    Mount Sinai Medical Center
Mar 4, 2022

Diabetes, Myocardial Infarction Trial in Miami Beach (disodium EDTA, Oral Multi Vitamins/Minerals (OMVM), Placebo disodium EDTA)

Active, not recruiting
  • Diabetes
  • Myocardial Infarction
  • disodium EDTA
  • +3 more
  • Miami Beach, Florida
    Mount Sinai Medical Center
Mar 30, 2022

Amyotrophic Lateral Sclerosis Trial in France (Deferiprone, Placebo Oral Tablet)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Angers, France
  • +14 more
Nov 4, 2022

Thalassemia, Iron Overload Trial in Oakland (Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO))

Completed
  • Thalassemia
  • Iron Overload
  • Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)
  • Oakland, California
    CHRCO
Jul 20, 2021

Thalassemia Major Trial in New York, Bangkok, Chiang Mai (DST-0509, Jadenu, Exjade)

Completed
  • Thalassemia Major
  • New York, New York
  • +3 more
Jan 31, 2022

Beta Thalassemia Major Trial in Tirana (Emeramide)

Completed
  • Beta Thalassemia Major
  • Tirana, Albania
    University Hospital Center "Mother Theresa" Tirana
Aug 20, 2021

Transfusional Iron Overload, Iron Overload, Iron Chelation Trial (SPD602, Deferasirox)

Withdrawn
  • Transfusional Iron Overload
  • +6 more
  • (no location specified)
Jun 1, 2021

Iron Overload Due to Repeated Red Blood Cell Transfusions Trial in Worldwide (SPD602)

Terminated
  • Iron Overload Due to Repeated Red Blood Cell Transfusions
  • Los Angeles, California
  • +11 more
Jun 11, 2021

THALASSEMIA MAJOR Trial in Oakland (Blood Draw/Semen Exam, Retrospective data/Chart Review/Relevant Clinical Results, Pituitary

Completed
  • THALASSEMIA MAJOR
  • Blood Draw/Semen Exam
  • +2 more
  • Oakland, California
    UCSF Benioff Children's Hospital Oakland
Dec 22, 2020

Parkinson Disease Trial in Worldwide (Deferiprone, Placebo)

Active, not recruiting
  • Parkinson Disease
  • Innsbruck, Austria
  • +24 more
Mar 9, 2021

Assess Iron Chelation Therapy in Chronic Iron Overload

Completed
  • Chronic Iron Overload
  • Iron chelator
  • Winnenden, Baden Wuerttemberg, Germany
  • +102 more
Jun 29, 2022

Iron Overload, Oxidative Stress, Thalassemia Major Trial in Bani Suwayf, Mecca (Omega 3, Nigella Sativa Oil, Hydroxyurea)

Completed
  • Iron Overload
  • +2 more
  • Omega 3
  • +5 more
  • Banī Suwayf, Egypt
  • +3 more
Jan 25, 2021

Transfusional Iron Overload, Beta-thalassemia Trial in Worldwide (SPD602 (FBS0701, SSP-004184))

Completed
  • Transfusional Iron Overload
  • Beta-thalassemia
  • SPD602 (FBS0701, SSP-004184)
  • Oakland, California
  • +8 more
May 30, 2021

Ketotifen: asCardioprotective Agent in Breast Cancer Patients

Completed
  • Breast Cancer
  • Iron Chelation
  • Ketotifen 1 MG
  • Damietta, Damiete Governonate, Egypt
    Horus University
Jun 15, 2020

Cognitive Function and Quality of Life in Thalassemic Children

Not yet recruiting
  • Thalassemia
  • Pediatric Quality of Life Inventory (questionnaire) and The Stanford-Binet Intelligence Scale fifth edition
  • Sohag, Egypt
    Sohag university Hospital
Sep 25, 2023

Cardiac Function in Patients With Hereditary Hemochromatosis

Completed
  • Hereditary Hemochromatosis
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Jan 27, 2023

    Aplastic Anemia Trial in Moscow (ICL670, Chelation, No chelation)

    Terminated
    • Aplastic Anemia
    • Moscow, Russian Federation
      Novartis Investigative Site
    Jul 8, 2019

    Critical Limb Ischemia, Peripheral Arterial Disease Trial in Miami Beach (disodium EDTA)

    Completed
    • Critical Limb Ischemia
    • Peripheral Arterial Disease
    • disodium EDTA
    • Miami Beach, Florida
      Mount Sinai Medical Center
    Jun 6, 2019

    MDS Trial in Beijing (Lenalidomide, Azacitidine)

    Not yet recruiting
    • Myelodysplastic Syndromes
    • Beijing, China
      Peking union medical college hospital
    Aug 16, 2023

    a-thalassemia Trial in Nanning (a-globin restored autologous hematopoietic stem cells)

    Recruiting
    • α-thalassemia
    • α-globin restored autologous hematopoietic stem cells
    • Nanning, Guangxi, China
      PLA Joint Logistic Support Force No. 923 Hospital
    May 6, 2023

    ß-thalassemia Trial in Shenzhen (ß-globin restored autologous hematopoietic stem cells)

    Recruiting
    • β-thalassemia
    • β-globin restored autologous hematopoietic stem cells
    • Shenzhen, Guangdong, China
      Shenzhen University General Hospital
    May 8, 2023

    MDS, Del(5Q), Anemia Trial in Italy (Luspatercept Injection [Reblozyl])

    Recruiting
    • Myelodysplastic Syndromes
    • +3 more
    • Luspatercept Injection [Reblozyl]
    • Alessandria, Italy
    • +22 more
    Jun 20, 2023